BIOSCIENCE NEUTRACEUTICALS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
BIOSCIENCE NEUTRACEUTICALS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$626.05 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$154.37K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$9.27K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$15.31K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$447.10K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$626.05K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$73.54K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$154.37K derived: 10-K 12 month − 3 quarters · filed 2020-03-30 | -$163.63K derived: sum of 2 quarters · filed 2020-03-30 | -$178.95K derived: sum of 3 quarters · filed 2020-03-30 | -$626.05K 10-K · filed 2020-03-30 |
| 2019-09-30 | -$9.27K 10-Q · filed 2019-11-12 | -$24.58K derived: sum of 2 quarters · filed 2019-11-12 | -$471.68K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2019-06-30 | -$15.31K 10-Q · filed 2019-11-12 | -$462.41K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2019-03-31 | -$447.10K 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | -$73.54K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$10.98K 10-Q · filed 2019-11-12 | -$37.60K derived: sum of 2 quarters · filed 2019-11-12 | -$49.73K derived: sum of 3 quarters · filed 2019-11-12 | |
| 2018-06-30 | -$26.62K 10-Q · filed 2019-11-12 | -$38.75K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-03-31 | -$12.13K 10-Q · filed 2019-11-12 |